Current indications for acid suppressants in dyspepsia

Best Practice and Research: Clinical Gastroenterology

Volumn 15, Issue 3, 2001, Pages 385-400

  Bytzer, Peter ^a   Talley, Nicholas J ^b  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Controlled trials; Dyspepsia; Functional dyspepsia; H2 receptor antagonists; Management; Proton pump inhibitors

Indexed keywords

ALGINIC ACID; CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; NIZATIDINE; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE; STOMACH SECRETION INHIBITOR;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG INDICATION; DRUG RESPONSE; DYSPEPSIA; EVALUATION; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MEDICAL DOCUMENTATION; PREDICTION; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SHORT COURSE THERAPY; TREATMENT OUTCOME;

EID: 0034954693     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2001.0186     Document Type: Article

References (63)

1. Dyspepsia in general practice in Denmark
2. Dyspepsia workload in urban general practice and implications of the British Society of Gastroenterology dyspepsia guidelines (1996)
3. Prescribing patterns for dyspepsia in primary care: A prospective study of selected general practitioners
4. The Diagnosis and Therapy Survey October 1978-March 1983. Health care consumption and current drug therapy in Sweden with respect to the clinical diagnosis of gastritis
5. Repeat prescribing of ulcer healing drugs in general practice-prevalence and underlying diagnosis
6. Long term acid suppressing treatment in general practice
7. [Availability of potent ulcer medicine over-the-counter]
8. [The basis for employment of ulcer medicine in general practice]
9. Survey of prescriptions for peptic ulcer drugs (ACT Class AOB2) in Iceland
10. Endoscopy in the evaluation of dyspepsia
11. Dyspepsia: A dilemma for doctors?
12. Management of uninvestigated and functional dyspepsia: A working party report for the World Congresses of Gastroenterology
13. Management of dyspeptic patients in primary care. Value of the unaided clinical diagnosis and of dyspepsia subgrouping
14. Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice
15. Antisecretory therapy in 1017 patients with ulcerlike or refluxlike dyspepsia in general practice
16. First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid/alginate liquid: A multicentre study in general practice
17. The management of acid-related dyspepsia in general practice: A comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy
18. Use of H2-receptor antagonists in patients with dyspepsia and heartburn: A cost comparison
19. 2-blocker therapy or prompt endoscopy in management of dyspepsia
20. Randomized controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: A cost-effectiveness analysis
21. Randomised controlled trial of four dyspepsia management strategies in primary care with 12 months follow-up
22. Design of treatment trials of functional gastrointestinal disorders
23. The treatment of non-ulcer dyspepsia
24. Cimetidine in the management of symptomatic patients with duodenitis. A double-blind controlled trial
25. [Cimetidine therapy in radio-negative dyspepsia]
26. Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia
27. Effect of cimetidine in patients with non-ulcer dyspepsia and erosive prepyloric changes
28. Symptomatic treatment of non-ulcer dyspepsia with cimetidine
29. A controlled trial of cimetidine for the treatment of nonulcer dyspepsia
30. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia
31. Non-ulcer dyspesia in Nigerians: Clinical and therapeutic results
32. Dyspepsia: Incidence of non-ulcer disease in a controlled trial of ranitidine in general practice
33. Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin
34. Clinical investigation of ranitidine in patients with gastritis
35. Cimetidine in the treatment of non-ulcer dyspepsia: Results of a randomized double-blind, placebo-controlled study
36. Ranitidine in the treatment of non-ulcer dyspepsia
37. Ranitidine effectively relieves symptoms in a subset of patients with functional dyspepsia
38. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia
39. Short course acid suppressive treatment for patients with functional dyspepsia: Results depend on Helicobacter pylori status
40. Efficacy of omeprazole in functional dyspepsia: Double-blind, randomized, placebo-controlled trials (the Bond and Opera studies)
41. No H. pylori: Less dyspepsia?
42. Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern
43. No effects of omeprazole in treatment of non-ulcer dyspepsia
44. Effect of omeprazole in functional dyspepsia: A double-blind, randomized, placebo-controlled study
45. Low-dose lansoprazole: Effective for non-ulcer dyspepsia
46. Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia
47. The effect of cimetidine in non-ulcer dyspepsia. Experience with a multi-cross-over model
48. Cimetidine responders in non-ulcer dyspepsia
49. The symptomatic effect of 1-day treatment periods with cimetidine in dyspepsia. Combined results from randomized, controlled, single-subject trials
50. Ranitidine for non-ulcer dyspepsia. A clinical study of the symptomatic effect of ranitidine and a classification and characterization of the responders to treatment
51. Cimetidine on-demand in dyspepsia. Experience with randomized controlled single-subject trials
52. Are frequent short gastro-oesophageal reflux episodes the cause of symptoms in patients with non-ulcer dyspepsia responding to treatment with ranitidine?
53. Response to acid suppression in dyspepsia. Identifying responders with a random starting day trial
54. Drug treatment of functional dyspepsia. A metaanalysis of randomized controlled clinical trials
55. Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia
56. Pharmacological interventions for non-ulcer dyspepsia
57. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders
58. Classification of dyspepsia. Identification of independent symptom components in 7270 consecutive, unselected dyspepsia patients from general practice
59. Irritable bowel syndrome and dyspepsia in the general population: Overlap and lack of stability over time
60. A survey of dyspepsia in Great Britain
61. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population
62. Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole
63. Helicobacter pylori and functional dyspepsia: A real causal link?